🇺🇸 FDA

Intelligence · Patent portfolio

AXIM Biotechnologies Patents

Full USPTO pharma patent portfolio for AXIM Biotechnologies — grant dates, expiration, and drug cross-links.

Patents
138
Expiring ≤24m
3

Quick answer

AXIM Biotechnologies has 138 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 3

  1. US 12391732

    Articles comprising a silk polypeptide for antigen delivery

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12379385

    Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12318397

    Methods and compositions for testosterone production

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12290524

    Methods and compositions for testosterone production

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12171837

    Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12168718

    Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12144876

    Security mechanisms for radiopharmaceutical elution system and elution process

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12133890

    Antigen-binding polypeptide targeting B7H3 and application thereof

    Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12129222

    Production of bitter principle derivatives

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12018125

    Block-copolymers for the delivery of active agents

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11904028

    Security mechanisms for radiopharmaceutical elution system and elution process

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11891436

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11857647

    Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11827678

    Articles comprising a silk polypeptide for antigen delivery

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11760795

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11746124

    Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11723922

    CXCR6-transduced T cells for targeted tumor therapy

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11693015

    Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11672771

    Beta-alethine, immune modulators, and uses thereof

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11667683

    Articles comprising a silk polypeptide for antigen delivery

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11634482

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11542226

    Polyfunctional cannabinoids

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11464856

    Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11427644

    Dual antigen-induced bipartite functional complementation

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11357842

    PD-L1 targeting DNA vaccine for cancer immunotherapy

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11351276

    Radiopharmaceutical compositions of radioactive halogenated benzylguanidine

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11229700

    Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11206824

    Gas delivery device comprising a gas releasing molecule and a gas permeable membrane

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11180518

    Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11161873

    Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11149073

    ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11104708

    Articles comprising a silk polypeptide for antigen delivery

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11028144

    Soluble glycoprotein V for treating thrombotic diseases

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10980868

    VEGFR-2 targeting immunotherapy approach

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10941200

    TREM2 cleavage modulators and uses thereof

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10905752

    VEGFR-2 targeting DNA vaccine for combination therapy

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10821163

    Process for the production of a DNA vaccine for cancer immunotherapy

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10822378

    Mutated structural protein of a parvovirus

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10815455

    Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10781251

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10663473

    Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10633451

    Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10604565

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10543190

    Suppositories comprising cannabinoids

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10513532

    Compound containing dexpanthenol

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10441645

    MSLN targeting DNA vaccine for cancer immunotherapy

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10441552

    Anti-microbial composition comprising cannabinoids

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10434117

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does AXIM Biotechnologies have?

138 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do AXIM Biotechnologies patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.